HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tamta Kobakhidze Selected Research

NI-0101

1/2020Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tamta Kobakhidze Research Topics

Disease

1Rheumatoid Arthritis
01/2020
1Rheumatic Diseases (Rheumatism)
01/2020

Drug/Important Bio-Agent (IBA)

1NI-0101IBA
01/2020
1acetyl 4-aminosalicylic acidIBA
01/2020
1Anti-Citrullinated Protein AntibodiesIBA
01/2020
1Monoclonal AntibodiesIBA
01/2020
1Antigen-Antibody Complex (Immune Complex)IBA
01/2020
1C-Reactive ProteinIBA
01/2020
1Methotrexate (Mexate)FDA LinkGeneric
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020
1Toll-Like Receptor 4IBA
01/2020